Meghna Jani Selected Research

Meghna Jani Research Topics

14	Rheumatoid Arthritis 07/2023 - 09/2011
6	Psoriatic Arthritis 01/2024 - 07/2015
5	Necrosis 12/2023 - 02/2015
4	Neoplasms (Cancer) 07/2023 - 10/2020
3	Musculoskeletal Diseases (Musculoskeletal Disease) 07/2023 - 11/2018
2	Fibromyalgia (Fibrositis) 07/2023 - 10/2020
2	Infections 10/2022 - 01/2019
2	Cancer Pain 11/2021 - 10/2020
2	Vasculitis (Vasculitides) 11/2018 - 01/2017
2	Weight Gain 02/2018 - 01/2018
2	Sleep Initiation and Maintenance Disorders (Insomnia) 02/2018 - 01/2018
1	Osteoarthritis 07/2023
1	COVID-19 07/2023
1	Axial Spondyloarthritis 07/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2023
1	Joint Diseases (Joint Disease) 11/2022
1	Leukopenia 10/2022
1	Colorectal Neoplasms (Colorectal Cancer) 10/2022
1	Stroke (Strokes) 10/2022
1	Pancytopenia 10/2022
1	Myocardial Infarction 10/2022
1	Body Weight (Weight, Body) 01/2022
1	Hypertension (High Blood Pressure) 01/2021
1	Substance-Related Disorders (Drug Abuse) 10/2020
1	Alcoholism (Alcohol Abuse) 10/2020
1	Synovitis 10/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2019
1	Drug-Related Side Effects and Adverse Reactions 02/2018
1	Pneumonia (Pneumonitis) 12/2017
1	Coinfection 12/2017
1	Rheumatic Diseases (Rheumatism) 05/2015
1	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2014
1	Crohn Disease (Crohn's Disease) 02/2014
1	Cryptococcal Meningitis 09/2011
1	Asthma (Bronchial Asthma) 10/2005

8	AntibodiesIBA 01/2021 - 02/2014
7	Adalimumab (Humira)FDA Link 01/2024 - 05/2015
6	Etanercept (Enbrel)FDA Link 01/2024 - 05/2015
6	Antirheumatic Agents (DMARD)IBA 01/2024 - 07/2015
6	Opioid Analgesics (Opioids)IBA 07/2023 - 01/2019
4	Tumor Necrosis Factor InhibitorsIBA 12/2023 - 06/2017
4	GlucocorticoidsIBA 01/2021 - 06/2017
3	Infliximab (Remicade)FDA Link 11/2022 - 06/2017
3	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 02/2014
3	Certolizumab Pegol FDA Link 01/2021 - 01/2017
2	MMEIBA 07/2023 - 10/2020
2	golimumab FDA Link 01/2021 - 06/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 05/2015
2	SteroidsIBA 01/2019 - 10/2005
2	tocilizumab (atlizumab)FDA Link 01/2019 - 06/2017
2	Abatacept (Orencia)FDA Link 06/2017 - 03/2012
2	Rituximab (Mabthera)FDA Link 06/2017 - 09/2011
1	GoldIBA 01/2023
1	A 17 (A-17)IBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	EnzymesIBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	C-Reactive ProteinIBA 10/2020
1	Pharmacological BiomarkersIBA 01/2020
1	InterferonsIBA 06/2019
1	sarilumabIBA 06/2017
1	tofacitinibIBA 06/2017
1	clazakizumabIBA 06/2017
1	Janus KinasesIBA 06/2017
1	baricitinibIBA 06/2017
1	Biosimilar PharmaceuticalsIBA 06/2017
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 06/2017
1	Leflunomide (Arava)FDA LinkGeneric 06/2017
1	Janus Kinase InhibitorsIBA 06/2017
1	sirukumabIBA 06/2017
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2015